GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Shandong Jincheng Pharmaceutical Group Co Ltd (SZSE:300233) » Definitions » 5-Year RORE %

Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) 5-Year RORE % : -3.03% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shandong Jincheng Pharmaceutical Group Co 5-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Shandong Jincheng Pharmaceutical Group Co's 5-Year RORE % for the quarter that ended in Mar. 2024 was -3.03%.

The industry rank for Shandong Jincheng Pharmaceutical Group Co's 5-Year RORE % or its related term are showing as below:

SZSE:300233's 5-Year RORE % is ranked worse than
62.16% of 1340 companies
in the Chemicals industry
Industry Median: 5.265 vs SZSE:300233: -3.03

Shandong Jincheng Pharmaceutical Group Co 5-Year RORE % Historical Data

The historical data trend for Shandong Jincheng Pharmaceutical Group Co's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Jincheng Pharmaceutical Group Co 5-Year RORE % Chart

Shandong Jincheng Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
5-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.36 -497.37 2,227.27 -30.77 23.33

Shandong Jincheng Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 105.56 338.10 235.29 23.33 -3.03

Competitive Comparison of Shandong Jincheng Pharmaceutical Group Co's 5-Year RORE %

For the Chemicals subindustry, Shandong Jincheng Pharmaceutical Group Co's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Jincheng Pharmaceutical Group Co's 5-Year RORE % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Shandong Jincheng Pharmaceutical Group Co's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Shandong Jincheng Pharmaceutical Group Co's 5-Year RORE % falls into.



Shandong Jincheng Pharmaceutical Group Co 5-Year RORE % Calculation

Shandong Jincheng Pharmaceutical Group Co's 5-Year RORE % for the quarter that ended in Mar. 2024 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( 0.54-0.53 )/( 0.67-1 )
=0.01/-0.33
=-3.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2024 and 5-year before.


Shandong Jincheng Pharmaceutical Group Co  (SZSE:300233) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Shandong Jincheng Pharmaceutical Group Co 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of Shandong Jincheng Pharmaceutical Group Co's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Shuangshan Road, Zichuan Economic Development Zone, Shandong, Zibo, CHN, 255100
Shandong Jincheng Pharmaceutical Group Co Ltd is engaged in the research and development, production and sale of III and IV cephalosporin intermediates and biopharmaceuticals. It offers characteristic bulk drugs, pharmaceutical intermediates, and fine chemicals. The company distributes its products within domestic market and to overseas markets.
Executives
Yang Xiu Liang Executives
Zhang Xue Bo Director
Zheng Geng Xiu Director
Zhao Ye Qing Director
Sun Rui Mei Executives
Cui Xi Li Executives
Zhao Hong Fu Director
Fu Miao Qing Executives
Zhu Xiao Gang Directors, executives
Li Jia Quan Directors, executives
Guo Fang Shui Supervisors
Chou Qiang Securities Affairs Representative

Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Headlines

No Headlines